Sameer Bhalla
Internal Medicine · Chicago, ILNPI 1962066365
Payments from drug & device makers
Across 85 payments — averaging $37.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- 3-d Matrix, Inc.$611
- AbbVie$563
- Johnson & Johnson$420
- Regeneron Healthcare Solutions, Inc.$355
- Takeda Pharmaceuticals U.S.A., Inc.$233
- Madrigal Pharmaceuticals$217
- plus $813 from 12 others
What the payments were for
- Food & beverage$3,02994%
- Education$1836%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| 3-d Matrix, Inc. | 1 | $611 |
| AbbVie | 14 | $563 |
| Johnson & Johnson | 14 | $420 |
| Regeneron Healthcare Solutions, Inc. | 6 | $355 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $233 |
| Madrigal Pharmaceuticals | 4 | $217 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $164 |
| Intercept Pharmaceuticals, Inc. | 6 | $140 |
| Sanofi | 4 | $118 |
| Celltrion USA Inc. | 5 | $102 |
| Pfizer | 5 | $83 |
| Vivus LLC | 2 | $45 |
| Novo Nordisk | 2 | $42 |
| Lilly USA, LLC | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,212 in reported general payments places this provider in the 85th percentile of 5,182 internal medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Chicago
- Dennis LevinsonChicago$25.3M
- Danny SugimotoChicago$4M
- Peter O DonnellChicago$3.9M
- Daniel CatenacciChicago$3.5M
- Patricia WalshChicago$2.1M
- Merle DiamondChicago$1.7M
- Mohammed KassemChicago$1.3M
- David BakerChicago$1M
- Azazuddin AhmedChicago$912K
- Daniel BergerChicago$861K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.